Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Arthritis & Rheumatism

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/art.33395PMID 21968701PMCID PMC3288585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exon 6 variants carried on systemic lupus erythematosus (SLE) risk haplotypes modulate IRF5 function

  2011cited by this paper
• The type I interferon system in the development of lupus.

  2011cited by this paper
• Innate Immune Sensing of DNA

  2011cited by this paper
• The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal.

  2010cited by this paper
• Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus

  2010cited by this paper
• North American Porcine Reproductive and Respiratory Syndrome Viruses Inhibit Type I Interferon Production by Plasmacytoid Dendritic Cells

  2010cited by this paper
• Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

  2010cited by this paper
• Potential role of IFNα in adult lupus

  2010cited by this paper
• IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway*

  2009cited by this paper
• Immunogenic and tolerogenic cell death

  2009cited by this paper
• Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C.

  2008cited by this paper
• Interferon regulatory factor 7‐mediated responses are defective in cord blood plasmacytoid dendritic cells

  2008cited by this paper
• Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.

  2008cited by this paper
• Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans

  2008cited by this paper
• Apoptosis in the pathogenesis of systemic lupus erythematosus

  2008cited by this paper
• DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

  2007cited by this paper
• Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population

  2007cited by this paper
• Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus

  2007cited by this paper
• Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression

  2007cited by this paper
• Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow.

  2006cited by this paper
• Just a Few Computational Principles Generate a Realistic Model of the Brain's Visual System

  2006cited by this paper
• Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.

  2006cited by this paper
• Receptor Cross-Linking on Human Plasmacytoid Dendritic Cells Leads to the Regulation of IFN-α Production1

  2006cited by this paper
• New insights into the pathogenesis of systemic lupus erythematosus

  2005cited by this paper
• Two Discrete Promoters Regulate the Alternatively Spliced Human Interferon Regulatory Factor-5 Isoforms

  2005cited by this paper
• Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death.

  2005cited by this paper
• Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

  2005cited by this paper
• The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling*

  2005cited by this paper
• Impaired clearance of dying cells in systemic lupus erythematosus.

  2005cited by this paper
• Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

  2004cited by this paper
• Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection*

  2004cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.

  2003cited by this paper
• Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1

  2002cited by this paper
• Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.

  2002cited by this paper
• Multiple Regulatory Domains of IRF-5 Control Activation, Cellular Localization, and Induction of Chemokines That Mediate Recruitment of T Lymphocytes

  2002cited by this paper
• Systemic lupus erythematosus disease activity index 2000.

  2002cited by this paper
• Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity

  2001cited by this paper
• Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon α Genes*

  2001cited by this paper
• Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility

  2000cited by this paper
• Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon‐alpha (IFN‐α) production acting on leucocytes resembling immature dendritic cells

  1999cited by this paper
• Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display.

  1999cited by this paper
• Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone.

  1990cited by this paper
• Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes.

  1988cited by this paper
• The biology of macrophages.

  1985cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Immune interferon in the circulation of patients with autoimmune disease.

  1979cited by this paper
• The Regulation of Lymphocyte Functions by the Macrophage

  1978cited by this paper

• The IRF transcription factor family in type I interferon-mediated antiviral immunity and associated diseases

  2026cites this paper
• Dysregulation of T Follicular Helper and Regulatory Cells in IRF5-SLE Homozygous Risk Carriers and Systemic Lupus Erythematosus Patients

  2025cites this paper
• Interferon regulatory factor 5: a potential target for therapeutic intervention in inflammatory diseases

  2025cites this paper
• TLR-induced STK25 activation promotes IRF5-mediated inflammation

  2025cites this paper
• IRF5 Controls Plasma Cell Generation and Antibody Production via Distinct Mechanisms Depending on the Antigenic Trigger

  2024cites this paper
• Pristane modulates specific changes on T cell dependent pathway of lupus in non-F1 BALB/c mice

  2024cites this paper
• Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes

  2024cites this paper
• Targeting type I interferons in systemic lupus erythematous

  2023cites this paper
• Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future)

  2021cites this paper
• Phosphorylation of Microglial IRF5 and IRF4 by IRAK4 Regulates Inflammatory Responses to Ischemia

  2021cites this paper
• JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology

  2021cites this paper
• The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial

  2021cites this paper
• Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease

  2021cites this paper
• Plasma microparticles from patients with systemic lupus erythematosus modulate the content of miRNAs in U937 cells

  2021cites this paper
• PATHOGENETIC VALUE OF CELL INFILTRATE IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES

  2021cites this paper
• Interferon regulatory factor 5 in Rheumatoid arthritis and systemic lupus erythematosus

  2021cites this paper
• Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus

  2020cites this paper
• Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.

  2020cites this paper
• Inhibition of IRF5 hyper-activation protects from lupus onset and severity.

  2020cites this paper
• Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization

  2020cites this paper
• SLE-associated risk factors affect DC function

  2019cites this paper
• HMGB1–C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis

  2019cites this paper
• Regulating IRFs in IFN Driven Disease

  2019cites this paper
• Grass carp (Ctenopharyngodon idellus) TRAF6 up-regulates IFN1 expression by activating IRF5.

  2019cites this paper
• Updated advances of linking psychosocial factors and sex hormones with systemic lupus erythematosus susceptibility and development

  2019cites this paper
• Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

  2019cites this paper
• IRF5 genetic risk variants drive myeloid-specific IRF5 hyper-activation and pre-symptomatic SLE.

  2019influential citation
• Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes

  2019cites this paper
• Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE

  2019cites this paper
• Monocytes of newly diagnosed juvenile DM1 patients are prone to differentiate into regulatory IL-10+ M2 macrophages

  2019cites this paper
• Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.

  2018cites this paper
• IRF5-mediated immune responses and its implications in immunological disorders

  2018cites this paper
• IRF-5 Promotes Cell Death in CD4 T Cells during Chronic Infection.

  2018cites this paper
• Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells

  2018cites this paper
• Corrected and Republished from: The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability

  2018influential citation
• B Cell-Intrinsic Role for IRF5 in TLR9/BCR-Induced Human B Cell Activation, Proliferation, and Plasmablast Differentiation

  2018cites this paper
• IRF-5 Promotes Cell Death in CD 4 T Cells during Chronic Infection Graphical

  2018cites this paper
• Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?

  2018cites this paper
• Phos-tag Immunoblot Analysis for Detecting IRF5 Phosphorylation.

  2017cites this paper
• Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

  2017cites this paper
• RNAi Screen and Proteomics Reveal NXF1 as a Novel Regulator of IRF5 Signaling

  2017cites this paper
• IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors

  2017cites this paper
• Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients.

  2017cites this paper
• Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.

  2017cites this paper
• Interferon regulatory factor signaling in autoimmune disease

  2017cites this paper
• Interferon Regulatory Factor 5 (IRF5) Interacts with the Translation Initiation Complex and Promotes mRNA Translation During the Integrated Stress Response to Amino Acid Deprivation

  2017cites this paper
• Expression of interferon regulatory factor 5 is regulated by the Sp1 transcription factor.

  2016influential citation
• Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease.

  2016cites this paper
• Mangiferin inhibits macrophage classical activation via downregulating interferon regulatory factor 5 expression

  2016cites this paper
• DNA-reactive B cells in lupus.

  2016cites this paper
• Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality

  2016cites this paper
• Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.

  2016cites this paper
• SLE‐associated risk factors affect DC function

  2015cites this paper
• Mathematical Modelling of Inter- and Intracellular Signal Transduction: The Regulatory Role of Multisite Interactions

  2015cites this paper
• Extracellular, but not intracellular HMGB1, facilitates self-DNA induced macrophage activation via promoting DNA accumulation in endosomes and contributes to the pathogenesis of lupus nephritis.

  2015cites this paper
• Imaging Immunosenescence.

  2015cites this paper
• Lupus-Associated Atherosclerosis Dysfunction in a Mouse Model of Promotes Atherosclerosis and Metabolic IRF 5 Deficiency Ameliorates Lupus but

  2015cites this paper
• IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5+ B‐ and T‐cell trafficking to tumor‐conditioned media

  2015cites this paper
• IRF5 Deficiency Ameliorates Lupus but Promotes Atherosclerosis and Metabolic Dysfunction in a Mouse Model of Lupus-Associated Atherosclerosis

  2015cites this paper
• High expression levels of microRNA-629, microRNA-525-5p and microRNA-516a-3p in paediatric systemic lupus erythematosus

  2014cites this paper
• Shear stress and interferon regulatory factor 5 modulate myeloid cell behaviour in atherosclerosis

  2014influential citation
• C1q-Mediated Repression of Human Monocytes Is Regulated by Leukocyte-Associated Ig-Like Receptor 1 (LAIR-1)

  2014cites this paper
• RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE

  2013cites this paper
• IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo

  2013cites this paper
• IRF5, IRF8, and IRF7 in human pDCs — the good, the bad, and the insignificant?

  2013cites this paper
• Interferon-Regulatory Factors Determine Macrophage Phenotype Polarization

  2013cites this paper
• The interferon signature in autoimmune diseases

  2013cites this paper
• Monocytes from Irf5−/− Mice Have an Intrinsic Defect in Their Response to Pristane-Induced Lupus

  2012cites this paper
• The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability

  2012influential citation
• Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response

  2012cites this paper
• Genetics of SLE: Functional Relevance for Monocytes/Macrophages in Disease

  2012influential citation